submit to the journals

Breast Cancer Journal Articles, Videos And Insights

Breast Cancer:FEATURED Articles

flipper_slider

Breast Cancer: Latest Articles

Breast Cancer: INSIGHTS

The touchONCOLOGY website provides a selection of resources to inform clinicians and patients about the latest developments in the field. The following are quick, non peer-reviewed, opinion-based updates addressing current trends and opinion on the most recent advances in the area of oncology:

Meeting Proceedings
Clinical Development of Taselisib in Advanced Breast Cancer Scrapped After Modest Efficacy Data Presented at ASCO Katrina Mountfort
Medical Writer, Touch Medical Media, UK
Insight
ECCO 2018 11th European Breast Cancer Conference – Industry Highlights Katrina Mountfort, Senior Medical Writer, Touch Medical Media, Reading, UK
Tim Sheldrick, Group Director and Advisory Editor, Touch Medical Media, Reading, UK
Risk Stratification of Patients with Hormone-Receptor Positive Breast Cancer to Optimise Treatment Selection Peter Schmid
Professor of Cancer Medicine and Clinical Director of the St. Bartholomew Breast Cancer Centre, UK
Molecular Re-classification of Breast Cancer – Part 2 Joyce O’Shaughnessy
Chair, Breast Cancer Research, Baylor University Medical Center, Texas Oncology and US Oncology, Dallas, TX, USA
Molecular Re-classification of Breast Cancer – Part 1 Rebecca Dent
Senior Consultant in Medical Oncology, National Cancer Center, Singapore

Breast Cancer:FEATURED VIDEOS

Editor's choice

Editorial board member, Eleni Andreopoulou, from Weill Cornell Medical College in New York, US, discusses molecular subtyping and advances in molecularly-targeted therapy in triple-negative breast cancer. Q1. What are the major challenges of treating triple-negative breast cancer? (0:11) Q2. How have advances in molecular subtyping impacted on the treatment of triple negative-breast cancer? (1:50) Q3. What unmet needs remain in molecularly targeted breast cancer therapy? (2:36) Q4. What innovations in clinical trial design are facilitating the development of therapies for high-risk, early-stage breast cancer? (3:41) Speaker disclosures: Eleni Andreopoulou has nothing to disclose in relation to this video interview. Filmed at the American Society of Clinical Oncology (ASCO) Annual Meeting 2018, Chicago, IL, US, June 1–5 2018
Serena Nik Zainal discusses the key themes of this year’s plenary lectures and new developments in the field. 1. What were the key themes of this year’s plenary lecture "Advances in the Understanding of Mutational Signatures in Human Cells"? (00:04) 2. What have been the key developments in your area of research over the past year? (01:01) 3. What new areas of research do you expect to emerge in 2018? (01:46) 4. Which sessions have interested you most at this year's SABCS? (02:39) Speaker disclosures: Serena Nik-Zainal has nothing to disclose in relation to this video interview. Filmed at the San Antonio Breast Cancer Symposium (SABCS), 40 Year Anniversary, San Antonio, Texas, USA, December 2017.

Breast Cancer:Latest Videos

Video List based on Category on Node Page

Latest Videos

Editorial board member, Eleni Andreopoulou, discusses interventions to improve the quality of life of patients with breast cancer throughout their treatment. Q. What personalized interventions improve the quality of life of breast cancer patients during and after chemotherapy treatment?...
Editorial board member, Eleni Andreopoulou, from Weill Cornell Medical College in New York, US, discusses molecular subtyping and advances in molecularly-targeted therapy in triple-negative breast cancer. Q1. What are the major challenges of treating triple-negative breast cancer?...
Giampaolo Bianchini from the IRCCS Ospendale San Raffaele, Milano, Lombardy, Italy, discusses why overall survival is considered the 'gold standard' endpoint for research into cancer agents and what this means for patients with metastatic breast cancer. 1. What is the clinical definition of...
John Crown talks to touchONCOLOGY about overall survival and what this means to patients with metastatic breast cancer. 1. Having extensive experience treating patients with metastatic breast cancer, what does extending life mean for them? (0:04) 2. Does life-extension remain an important...
Serena Nik Zainal discusses the key themes of this year’s plenary lectures and new developments in the field. 1. What were the key themes of this year’s plenary lecture "Advances in the Understanding of Mutational Signatures in Human Cells"? (00:04) 2. What have been the key developments...
Virginia G Kaklamani discusses endpoints of breast cancer trials and the potential for combination therapy. 1. What are the limitations as progression-free survival and overall survival as clinical endpoints in breast cancer trials? (00:04) 2. What other endpoints should be considered when...

LATEST TWEETS

Conference Highlights